GiftPad Inc., which supports digital transformation for local governments and companies, is pleased to announce that the number of users of "Health and Productivity Management Connecting Support ONLINE", a collaboration with Otsuka Pharmaceutical Co., Ltd. has exceeded 10,000. As Otsuka Pharmaceutical identified health issues and received consultations, it was found that each employee of the company had different health issues. Therefore, in 2022, we started working with Otsuka Pharmaceutical to create a web gift catalog that allows employees to choose what they want for themselves, rather than the company unilaterally deciding what health products to give them. Also Read: Nippon Brace announced “MEDIX-R,” that promotes medical digital transformation In recent years, with the growing awareness of health management due to announcements by the government and the Ministry of Economy, Trade…
SoftBank Corp. will begin offering "HacoBuddy," a service for the construction industry that supports digital…
Leading Mark Inc., which provides the HR platform "Mikiwame" to reduce "recruitment mismatch" and "employee…
Introduction As the global competition toward 6G technology is on the rise, Japan is distinctly…
Japan Display announced on February 12 that it will end panel production at its Mobara…
Guardant Health, Inc., a leading precision oncology company, and ConcertAI, a leading oncology real-world evidence data and AI SaaS technology…
CAC Corporation, a company working to bring about digital innovation in society and industry, will begin offering "Mamorimo," an AI…
FRONTEO and Maruishi Pharmaceutical Launch Co-Creation Project for Biomarker Discovery Using Drug Discovery AI Factory Accelerating research and development of prescription…
NEC Corporation (hereinafter referred to as NEC) and biomy, Inc. (hereinafter referred to as biomy) have signed a memorandum of…
Primo Biotechnology ("Primo") has announced a strategic collaboration with SHINE Technologies ("Shine"), a global leader in nuclear medicine manufacturing. The…
CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, announced it…
Daiichi Sankyo Company, Ltd announced that it will pay Glycotope $132.5 million to acquire intellectual property rights of the anti-tumor-associated…
Sign in to your account